These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms.
    Author: Sharma RP, Singh V, Janicak PG, Javaid JI, Pandey GN.
    Journal: Schizophr Res; 1999 Aug 23; 39(1):85-9. PubMed ID: 10480671.
    Abstract:
    We examined the serotonergic system in drug-free inpatients [schizophrenia (n=28) and schizoaffective (n=7)] by administering a challenge dose of oral dl-fenfluramine (fenfluramine) in a controlled angiocatheter study. Seventeen of these patients were also randomized to a placebo condition in addition to receiving fenfluramine. Response to fenfluramine as reflected by changes in serum prolactin and cortisol were examined by repeated measures ANOVA, as well as Area Under the Curves (AUCs). The prolactin response, but not the cortisol response, was significantly correlated with measures of negative symptoms.
    [Abstract] [Full Text] [Related] [New Search]